Ute Boon

1.4k total citations
6 papers, 713 citations indexed

About

Ute Boon is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Ute Boon has authored 6 papers receiving a total of 713 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 3 papers in Oncology and 3 papers in Cell Biology. Recurrent topics in Ute Boon's work include DNA Repair Mechanisms (3 papers), Microtubule and mitosis dynamics (3 papers) and PARP inhibition in cancer therapy (2 papers). Ute Boon is often cited by papers focused on DNA Repair Mechanisms (3 papers), Microtubule and mitosis dynamics (3 papers) and PARP inhibition in cancer therapy (2 papers). Ute Boon collaborates with scholars based in Netherlands, United Kingdom and Germany. Ute Boon's co-authors include Jos Jonkers, Ellen Wientjens, Rinske Drost, Sven Rottenberg, Ariena Kersbergen, Shridar Ganesan, Aaron Cranston, Serge A.L. Zander, Niall M.B. Martin and Liesbeth van Deemter and has published in prestigious journals such as Cancer Cell, British Journal of Cancer and Annals of Oncology.

In The Last Decade

Ute Boon

5 papers receiving 705 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ute Boon Netherlands	4	603	506	178	85	72	6	713
Ewa Gogola Netherlands	9	654 1.1×	544 1.1×	96 0.5×	98 1.2×	38 0.5×	11	812
Benjamin Primack United States	5	654 1.1×	387 0.8×	97 0.5×	97 1.1×	46 0.6×	10	748
Anbazhagan Rajendran United States	7	452 0.7×	318 0.6×	98 0.6×	51 0.6×	30 0.4×	7	572
Hatice Yücel Netherlands	4	506 0.8×	366 0.7×	89 0.5×	62 0.7×	26 0.4×	6	597
Niraj Joshi Canada	6	621 1.0×	271 0.5×	123 0.7×	100 1.2×	58 0.8×	7	695
Giuseppe Leuzzi United States	14	954 1.6×	386 0.8×	177 1.0×	106 1.2×	74 1.0×	17	1.1k
Rinske Drost Netherlands	12	1.0k 1.7×	794 1.6×	394 2.2×	170 2.0×	33 0.5×	14	1.2k
Kamakoti P. Bhat United States	7	937 1.6×	357 0.7×	96 0.5×	108 1.3×	104 1.4×	7	999
Ponnari Gottipati United Kingdom	7	786 1.3×	429 0.8×	112 0.6×	315 3.7×	18 0.3×	9	942

Countries citing papers authored by Ute Boon

Since Specialization

Citations

This map shows the geographic impact of Ute Boon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ute Boon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ute Boon more than expected).

Fields of papers citing papers by Ute Boon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ute Boon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ute Boon. The network helps show where Ute Boon may publish in the future.

Co-authorship network of co-authors of Ute Boon

This figure shows the co-authorship network connecting the top 25 collaborators of Ute Boon. A scholar is included among the top collaborators of Ute Boon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ute Boon. Ute Boon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Maia, Ana, Simon Linder, Ji‐Ying Song, et al.. (2018). Mps1 inhibitors synergise with low doses of taxanes in promoting tumour cell death by enhancement of errors in cell division. British Journal of Cancer. 118(12). 1586–1595. 33 indexed citations

2.

Puppe, Julian, Marieke van de Ven, Eline van der Burg, et al.. (2016). EZH2 inhibition sensitizes BRCA1-deficient breast tumors to the PI3K inhibitor BKM120. Geburtshilfe und Frauenheilkunde. 76(10). 1 indexed citations

3.

Maia, Ana, Ute Boon, Aniek Janssen, et al.. (2015). Inhibition of the spindle assembly checkpoint kinase TTK enhances the efficacy of docetaxel in a triple-negative breast cancer model. Annals of Oncology. 26(10). 2180–2192. 93 indexed citations

4.

Zaman, Guido J.R., Joost C.M. Uitdehaag, Ana Maia, et al.. (2015). Identification of selective inhibitors of the spindle assembly checkpoint kinase TTK (Mps1) for treatment of triple negative breast cancer. Annals of Oncology. 26. ii28–ii28. 1 indexed citations

5.

Jaspers, Janneke E., Ariena Kersbergen, Ute Boon, et al.. (2012). Loss of 53BP1 Causes PARP Inhibitor Resistance in Brca1 -Mutated Mouse Mammary Tumors. Cancer Discovery. 3(1). 68–81. 388 indexed citations

6.

Drost, Rinske, Peter Bouwman, Sven Rottenberg, et al.. (2011). BRCA1 RING Function Is Essential for Tumor Suppression but Dispensable for Therapy Resistance. Cancer Cell. 20(6). 797–809. 197 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact